Dáil Éireann Debate, Thursday - 23 February 2017
308. Deputy Carol Nolan asked the Minister for Health if the HSE review of the list of products available to phenylketonuria patients under the reimbursement scheme has been completed; and if he will make a statement on the matter. [9216/17]
Amharc ar fhreagra309. Deputy Carol Nolan asked the Minister for Health if consideration will be given to expanding the list of products available to phenyltketonuria,PKU, patients under the terms of the HSE reimbursement scheme; if he will update the current list to reflect products that are no longer available to patients; his views on whether the restriction of products available to PKU patients is in contradiction of the HSE's promotion of healthy diet for children and diet for life; and if he will make a statement on the matter. [9217/17]
Amharc ar fhreagra310. Deputy Carol Nolan asked the Minister for Health if consideration will be given to providing additional supports and resources in order to improve the treatment and care of phenylketonuria patients here; and if he will make a statement on the matter. [9219/17]
Amharc ar fhreagraI propose to take Questions Nos. 308 to 310, inclusive, together.
The Long Term Illness Scheme was established under Section 59(3) of the Health Act, 1970 (as amended). Under this scheme the HSE may make arrangements for the supply without charge of medicines or medical and surgical appliances to persons suffering from a prescribed disease or disability of a permanent or long-term nature, this includes PKU.
Under the Health (Pricing and Supply of Medicinal Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug scheme; therefore these matters have been referred to the HSE for attention and direct reply.
